AstraZeneca to acquire Gracell in $1.2 billion deal
AstraZeneca plc announced on Tuesday that it is set to acquire China-based global biopharmaceutical firm Gracell Biotechnologies in a deal estimated to be worth around $1.2 billion to use the latter…
